Screener / SEC EDGAR /CIK 0000943819 /10-K filed Aug 13, 2026, compared with Aug 8, 2025 /Numbers from the XBRL of the 10-Ks
NYSE, OTC Health care · Medical Instruments

ResMed RMD

Compare with peers Embed
SEC comment letters, last 20 years

1 review of RMD's filings by SEC staff

UPLOAD and CORRESP
Reviews 1 latest letter Feb 26, 2021
Questions asked 1 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 1 UPLOAD
  2. 2. Questions in them 1 numbered comments
  3. 3. Company replies 1 CORRESP
  4. 4. Reviews closed 1 of 1 closing letter

Half the closed reviews took 49 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended June 30, 2020

2021-02-26 to 2021-04-16 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2021-04-16
Item 15 - Exhibits and Consolidated Financial Statement Schedules, page 89
SEC asked
We note that there was no consent provided in Exhibit 23.1 as indicated. Please amend to file a consent signed by your independent registered certified public accounting firm. Refer to Item 601(b)(23)(i) of Regulation S-K.
RMD answered
In response to the Staff’s comment, we have filed an amendment to the 10-K to include a written consent from our independent auditors as an exhibit.

We acknowledge the Company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the Staff.

If you would like to discuss or have any additional questions or concerns, I can be contacted at +61 2 8884 2090.
Read in the reply
In its next report

First report after the company's reply of Mar 29, 2021: 10-Q filed Apr 30, 2021 ↗, against the 10-Q filed Jan 29, 2021 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2021-04-16

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 3 letters filed since 2021-02-26. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RMD/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.